Antiproliferative and cancer chemopreventive activity of phytoalexins: Focus on indole phytoalexins from crucifers

Neoplasma

Volumn 50, Issue 4, 2003, Pages 239-245

  Mezencev, R ^a   Mojzis J ^b   Pilatova M ^b   Kutschy, P ^b  

^a U N Monitor Verif/Inspect Comm   (United States)

^b P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Brassinin; Camalexin; Carcinogenesis; Chemoprevention; Phytoalexins; Spirobrassinin

Indexed keywords

1 METHOXYBRASSENIN; 1 METHOXYBRASSENIN B; 1 METHOXYBRASSININ A; 1 METHOXYBRASSITIN; 1 METHOXYSPIROBRASSININ; 1 METHOXYSPIROBRASSINOL; 4 METHOXYBRASSININ; 6 METHOXYCAMALEXIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BRASSICANAL A; BRASSICANAL B; BRASSICANAL C; BRASSILEXIN; BRASSININ; BRASSITIN; CAMALEXIN; CYCLOBRASSININ; CYCLOBRASSININ SULFOXIDE; CYCLOBRASSINONE; DEHYDRO 4 METHOXYCYCLOBRASSININ; DIOXIBRASSININ; INDOLE DERIVATIVE; METHOXYSPIROBRASSINOL METHYL ETHER; METHYL 1 METHOXYINDOLE 3 CARBOXYLATE; PHYTOALEXIN; SINALEXIN; SPIROBRASSININ; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BRASSICA; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL CYCLE; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CRUCIFERA; DRUG MECHANISM; FOOD INTAKE; IC 50; NONHUMAN; SHORT SURVEY; SKIN CARCINOGENESIS; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION; TUMOR DIFFERENTIATION; WINE;

EID: 0141761523     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (56)

1. ADHAMI VM, AFAQ F, AHMAD N. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells. Biochem Biophys Res Commun 2001; 288: 579-585.
2. ARAGONÓS J, LOPÉZ-RODRÍGUEZ C, CORBÍ A, GÓMEZ DEL ARCO P, LÓPEZ-CABRERA M, DE LANDÁZURI MO, REDONDO JM. Dithiocarbamates trigger differentiation and induction of CD11c gene through AP-1 in the myeloid lineage. J Biol Chem 1996; 271: 10924-10931.
3. BAILEY JA, MANSFIELD JW, editors. Phytoalexins. Glasgow, UK: Blackie, 1982.
4. BAILEY GS, DASHWOOD RH, FONG AT, WILLIAMS DE. Modulation of mycotoxin and nitrosamine carcinogenesis by indole-3-carbinol: quantitation analysis of inhibition versus promotion. IARC Sci Publ 1991; 105: 275-280.
5. BASLY J-P, MARRE-FOURNIER F, LE BAIL J-C, HABRIOUX G, CHULEA AJ. Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol. Life Sci 2000; 66: 769-777.
6. BHAT KP, LANTVIT D, CHRISTOV K, MEHTA RG, MOON RC, PEZZUTO JM. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 2001; 61: 7456-7463.
7. BRADLOW HL, MICHNOVICZ J, TELANG NT, OSBORNE MP. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis (Lond.) 1991; 12: 1571-1574.
8. CARBO N, COSTELLI P, BACCINO FM, LOPEZ-SORIANO FJ, ARGILES JM. Resveratrol, a natural product present in wine, decreases tumor growth in a rat tumour model. Biochem Biophys Res Commun 1999; 254: 739-743.
9. CHUNG FL, MORSE MA, EKLIND KI, XU Y. New potential chemopreventive agents of azoxymethane induced foci of aberrant crypts in rat colon. Ann NY Acad Sci 1993; 686: 186-201.
10. 1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem 1998; 273: 3838-3847.
11. DASHWOOD RH, FONG AT, HENDRICKS JD, BAILEY GS. Tumor dose response studies with aflatoxin B1 and the ambivalent modulator indole-3-carbinol: inhibitory versus promotional potency. Basic Life Sci 1990; 52: 361-365.
12. DEMEESTER SL, BUCHMAN TG, QIU Y, DUNNIGAN K, HOTCHKISS RS, KARL TE, COBB JP. Pyrolidine dithiocarbamate activates the heat shock response and thereby induces apoptosis in primed endothelial cells. Shock 1998; 10: 1-6.
13. ELATTAR TM, VIRJI AS. Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anticancer Drugs 1999; 10: 187-193.
14. FAHEY JW, ZHANG Y, TALALAY P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci 1997; 94: 10367-10372.
15. FALKIEWICZ B, LUKASIAK J. Vilcacora [Uncaria tomentosa (Willd.) DC. and Uncaria guianensis (Aublet) Gmell.] - a review of published scientific literature. Case Rep Clin Pract Rev 2001; 2: 305-316.
16. FENWICK GR, HEANEY RK, MAWSON R, editors. Toxicants of plant origin. Vol. 2. Cleveland: CRC Publishing Co, 1989.
17. FONTECAVE M, LEPOIVRE M, ELLEINGAND E, GEREZ C, GUITTET O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 1998; 421: 277-279.
18. GE X, YANNAI S, RENNERT G, GRUENER N, FARRES FA. 3,3′ -Diindolylmethane induces apoptosis in human cancer cells. Biochem Biophys Res Commun 1996; 228: 153-158.
19. GERHAUSER C, YOU M, LIU J, MORIARTY RM, HAWTHORNE M, MEHTA RG, MOON RC, PEZZUTO JM. Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res 1997; 57: 272-278.
20. GREENWALD P, NIXON DW, MALONE WF, KELLOFF GJ, STERN HR, WITKIN KM. Concepts of cancer chemoprevention. Cancer (Phil) 1990; 65: 1483-1490.
21. GRONBAEK M, DEIS A, SORENSEN TI, BECKER U, SCHNOHR P, JENSEN G. Mortality associated with moderate intakes of wine, beer, or spirits. Br Med J 1995; 310: 1165-1169.
22. GRUBBS CJ, STEELE VE, CASEBOLT T, JULIANA MM, ETO I, WHITAKER LM, DRAGNEV KH, KELLOFF GJ, LUBET RL. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 1995; 15: 709-716.
23. HECHT SS, CARMELLA SG, MURPHY SE. Effects of watercress consumption on urinary metabolites of nicotine in smokers. Cancer Epidemiol Biomarkers Prev 1999; 8: 907-913.
24. HOULBROOK S, CARMICHAEL J, DAVIES S. Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines. Br J Cancer 1995; 72: 1454-1461.
25. JANG M, CAI L, UDEANI GO, SLOWING KV, THOMAS CF, BEECHER CW, FONG HH, FARNSWORTH NR, KINGHORN AD, MEHTA RG, MOON RC, PEZZUTO JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science (Washington DC) 1997; 275: 218-220.
26. KATDARE M, OSBORNE MP, TELANG NT. Inhibition of aberrant proliferation and induction of apoptosis in pre-neoplastic human mammary epithelial cells by natural phytochemicals. Oncol Rep 1998; 5: 311-315.
27. KEPLINGER K, LAUS G, WURM M, DIETRICH MP, TAPPNER H. Uncaria tomentosa (Willd.) DC. - ethnomedicinal use and new pharmacological, toxicological and botanical results. J Ethnopharmacol 1999; 64: 23-34.
28. KIMBER DS, McGREGOR DI, editors. Brassica oilseeds. Wallingford, UK: CAB International, 1995.
29. LIU G-Y, FRANK N, BARTSCH H, LIN J-K. Induction of apoptosis by thiuramdisulfides, the reactive metabolites of dithiocarbamates, through coordinative modulation of NFκB c-fos/c-jun, and p53 proteins. Mol Carcinog 1998; 22: 235-246.
30. McNARY MH, BALDWIN AS JR. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IκB kinase. Cancer Res 2000; 60: 3477-3483.
31. MEHTA RG, HAWTHORNE ME, STEELE VE. Induction and prevention of carcinogen-induced precancerous lesions in mouse mammary gland organ culture. Methods Cell Sci 1997; 19: 19-24.
32. MEHTA RG, LIU J, CONSTANTINOU A, THOMAS CF, HAWTHORNE M, You M, GERHÄUSER C, PEZZUTO JM, MOON RC, MORIARTY RM. Cancer chemopreventive activity of brassinin, phytoalexin from cabbage. Carcinogenesis 1995; 16: 399-404.
33. MENTA RG, LIU J, CONSTANTINOU A, HAWTHORNE M, PEZZUTO JM, MOON RC, MORIARTY RM. Structure-activity relationships of brassinin in preventing the development of carcinogen-induced mammary lesions in organ culture. Anticancer Res 1994; 14: 1209-1214.
34. MEHTA RG, STEELE V, KELLOFF CJ, MOON RC. Influence of thiols and inhibitors of prostaglandin biosynthesis on the carcinogen-induced development of mammary lesions in vitro. Anticancer Res 1991; 11: 587-592.
35. MEHTA RG, MOON RC. Characterization of effective chemopreventive agents in mammary gland in vitro using an initiation-promotion protocol. Anticancer Res 1991; 11: 593-596.
36. MGBONYEBI OP, RUSSO J, RUSSO IH. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol 1998; 12: 865-869.
37. MICHNOVICZ JJ, BRADLOW HL. Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol. Nutr Cancer 1991; 16: 59-66.
38. MONDE K, TAKASUGI M, OHNISHI T. Biosynthesis of cruciferous phytoalexins. J Am Chem Soc 1994; 116: 6650-6657.
39. MOODY CJ, ROFFEY JRA, STEPHENS MA, STRATFORD IJ. Synthesis and cytotoxic activity of indolyl thiazoles. Anti-Cancer Drugs 1997; 8: 489-499.
40. OKA H, YOSHINARI T, MURAI T. A new topoisomerase-II inhibitor BE-10988, produced by a Streptomycete. I. Taxonomy, fermentation, isolation and characterization. J Antibiot 1991; 44: 486-491.
41. PEDRAS MSC, OKANGA FI, ZAHARIA IL, KHAN AQ. Phytoalexins from crucifers: synthesis, biosynthesis, and biotransformation. Phytochemistry 2000; 53: 161-176.
42. PENCE BC, BUDDING F, YANG SP. Multiple dietary factors in the enhancement of dimethylhydrazine carcinogenesis: main effects of indole-3-carbinol. J Natl Cancer Inst 1986; 77: 269-276.
43. RENAUD S, DE LORGERIL M. The French paradox: dietary factors and cigarette smoking-related health risks. Ann N Y Acad Sci 1993; 686: 299-309.
44. Report of the Chemoprevention Working Group to the American Association for Cancer Research. Prevention of cancer in the next millennium. Cancer Res 1999; 59: 4743-4758.
45. RICHARD JL. Coronary risk factors. The French paradox. Arch Mal Coeur Vaiss 1987; 80: 17-21.
46. SABOL M, KUTSCHY P, SIEGFRIED L, MIROŠŠAY A, SUCHÝ M, HRBKOVÁ H, DZURILLA M, MARUŠKOVÁ R, STARKOVÁ J, PAULÍKOVÁ E. Cytotoxic effect of cruciferous phytoalexins against murine L1210 leukemia and B16 melanoma. Biologia 2000; 55: 701-707.
47. SOLEAS GJ, DIAMANDIS EP, GOLDBERG DM. Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal 1997; 11: 287-313.
48. SUBBARAMAIAH K, CHUNG WJ, MICHALUART P, TELANG N, TANABE T, INOUE H, JANG M, PEZZUTO JM, DANNENBERG AJ. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 1998; 273: 21875-21882.
49. TAKASUGI M, KATSUI M, SHIRATA A. Isolation of three novel sulphur containing phytoalexins from the chinese cabbage Brassica campestris L. ssp. pekinensis. J Chem Soc Chem Commun 1986; 23: 1077-1078.
50. TEMPTE C, DEVYS M, BARBIER M. Growth inhibition of human cancer cell cultures with the indole-sulphur containing phytoalexins and their analogs. Z Naturforsch 1991; 46c: 706-707.
51. TSAI SH, LIN-SHIAU SY, LIN JK. Suppression of nitric oxide synthase and the down-regulation of the activation of NF-κB in macrophages by resveratrol. Br J Pharmacol 1999; 126: 673-680.
52. VERHOEVEN DTH, VERHAGEN H, GOLDBOHM RA, VAN DEN BRANDT PA, VAN POPPEL G. A review of mechanism underlying anticarcinogenicity by brassica vegetables. Chem-Biol Interact 1997; 103: 79-129.
53. WANG C-Y, MAYO MW, BALDWIN AS JR. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappa B. Science 1996; 274: 784-787.
54. WATTENBERG LW. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 1992; 52: 2085-2091.
55. WATTENBERG LW. Chemoprevention of cancer. Cancer Res 1985; 45: 1-8.
56. ZHANG Y, TALALAY P. Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. Cancer Res 1994; 54: 1976-1981.